SGLT2 inhibitors: A new class of medications for type 2 diabetes

Sodium-glucose co-transporter 2 inhibitors (SGLT2) inhibitors are a new category of medications for type 2 diabetes. As of June 2021, the SGLT2 inhibitors available in the US are (alphabetically) canagliflozin (Invokana®), dapagliflozin (Farxiga®), and empagliflozin (Jardiance®). We are mental health clinicians, so why do we care about SGLT2 inhibitors? What’s so special about them? Not…